BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on CILEST® and PRAMINO® tablets: Recall of the entire stock from the market

Active substance: ethinyl estradiol, norgestimate

The pharmaceutical manufacturer is sending out information on the recall of the entire stock of CILEST® and PRAMINO® from the market as both products are no longer available.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 337KB, File is accessible